Policymakers and clinicians should continue to closely monitor trade-offs between pharmacologic and surgical management of obesity to ensure optimal access to effective obesity treatment, the researchers concluded.
Then use iFIT nutrition content on protein for recovery and fueling and moving through low-energy days to make everyday choices easier
The Magnolia State faces higher rates of metabolic syndrome, diabetes, and cardiovascular disease than national averages, requiring targeted interventions beyond generic advice
In the Look AHEAD study, which examined the effect of intensive lifestyle intervention in patients with obesity and type 2 diabetes, the composite endpoint of adverse cardiovascular events and mortality was reduced by approximately 20% over a median follow-up period of 10.2 years, only in the group of patients that achieved a weight loss of 10% or more from their initial body weight (about 40% of the intervention arm) [7, 8]
Unlike quick-fix programs or fad diets, GLP-1 therapy targets the biological causes of weight gain
GLP-1 receptor agonists are a class of medications originally developed for type 2 diabetes management and now some are also licensed for weight management
